11 December 2015 - Outcomes for nintedanib esylate (Vargatef) and evolocumab (Repatha) from the March 2015 PBAC meeting and for simeprevir sodium (Olysio) and nivolumab (Opdivo) from the July 2015 PBAC meeting are now available.

For more details, go to: http://www.pbs.gov.au/info/news/2015/12/updated-pbac-outcomes-for-march-and-july-2015